inositol 1-phosphate has been researched along with endothelin-1 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cable, L; Glascock, CB; Hartman, JC; Liang, F; Melvin, L; Pitts, KR; Sandoval, J; Schafer, DL | 1 |
Clozel, M; Gatfield, J; Mueller Grandjean, C; Nayler, O; Sasse, T | 1 |
2 other study(ies) available for inositol 1-phosphate and endothelin-1
Article | Year |
---|---|
Darusentan is a potent inhibitor of endothelin signaling and function in both large and small arteries.
Topics: Animals; Aorta; Arterioles; Binding, Competitive; Calcium Signaling; Cell Membrane; Cells, Cultured; Endothelin A Receptor Antagonists; Endothelin-1; Inositol Phosphates; Male; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Signal Transduction; Stereoisomerism; Vasoconstriction | 2010 |
Slow receptor dissociation kinetics differentiate macitentan from other endothelin receptor antagonists in pulmonary arterial smooth muscle cells.
Topics: Animals; Bosentan; Calcium; CHO Cells; Clinical Trials, Phase III as Topic; Cricetinae; Endothelin Receptor Antagonists; Endothelin-1; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Inositol Phosphates; Myocytes, Smooth Muscle; Phenylpropionates; Pulmonary Artery; Pyridazines; Pyrimidines; Receptors, Endothelin; Sulfonamides | 2012 |